v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Cash flows from operating activities    
Net income (loss) $ 4,434 $ (37,626)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 5,555 5,309
Stock-based compensation 137,830 132,431
Amortization of finance right-of-use assets 994 993
Amortization of operating right-of-use assets 2,578 2,758
Deferred income taxes 19 25
Amortization of premium and accretion of discount on short-term investments, net (1,084) (3,800)
Realized and unrealized loss (gain) on financial instruments, net 16,420 (272)
Unrealized foreign exchange loss 148 1,970
Change in operating assets and liabilities:    
Accounts receivable, net 112,951 79,895
Prepaid expenses and other current assets (13,388) (4,973)
Deferred commissions 12,239 7,772
Other long-term assets 1,125 (12,593)
Accounts payable 20,496 (2,478)
Accrued liabilities (22,802) (19,353)
Operating lease liabilities (2,476) (2,688)
Deferred revenue (39,864) (39,624)
Other liabilities, non-current (704) 1,639
Net cash provided by operating activities 201,631 109,929
Cash flows from investing activities    
Purchases of property, equipment and other assets (2,319) (1,611)
Investments in non-marketable securities (3,000) (4,822)
Business combination, net of cash acquired 0 (2,032)
Proceeds from maturities of marketable securities 259,800 198,660
Proceeds from non-marketable securities 10,718 0
Purchases of marketable securities (352,122) (138,624)
Net cash provided by (used in) investing activities (86,923) 51,571
Cash flows from financing activities    
Repurchases of common stock (100,255) 0
Proceeds from exercise of stock options 461 579
Taxes paid related to net share settlement of equity awards (58,317) 0
Principal payments of finance leases (1,764) (2,394)
Net cash used in financing activities (159,875) (1,815)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (1,698) 8,000
Net increase (decrease) in cash, cash equivalents and restricted cash (46,865) 167,685
Cash, cash equivalents and restricted cash, beginning of period 1,086,625 492,753
Cash, cash equivalents and restricted cash, end of period 1,039,760 660,438
Cash paid during the period for:    
Income taxes, net of refunds 3,837 3,899
Interest expense 414 510
Noncash investing and financing activities:    
Issuance of common stock in connection with a business combination 0 141,402
Purchases of property and equipment included in accounts payable and accrued liabilities 2,641 274
Unpaid taxes for net share settlement of equity awards included in accrued compensation and benefits 5,417 0
Reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets, end of period, to the amounts shown in the statements of cash flows above:    
Cash and cash equivalents 1,036,354 657,809
Restricted cash, non-current 3,406 2,629
Total cash, cash equivalents and restricted cash $ 1,039,760 $ 660,438